Summit Global Investments purchased a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 27,181 shares of the company's stock, valued at approximately $571,000. Summit Global Investments owned approximately 0.07% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Rhumbline Advisers grew its holdings in Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC lifted its stake in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock worth $505,000 after acquiring an additional 503 shares in the last quarter. BNP Paribas Financial Markets grew its stake in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares in the last quarter. New York State Teachers Retirement System grew its stake in Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after purchasing an additional 906 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Finally, StockNews.com downgraded Phibro Animal Health from a "buy" rating to a "hold" rating in a research note on Tuesday. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and a consensus price target of $21.00.
View Our Latest Report on Phibro Animal Health
Phibro Animal Health Stock Performance
NASDAQ PAHC traded up $0.04 during trading hours on Thursday, reaching $21.68. The company's stock had a trading volume of 298,396 shares, compared to its average volume of 178,508. The stock has a market cap of $878.11 million, a PE ratio of 45.17, a PEG ratio of 0.45 and a beta of 0.58. The business has a 50-day simple moving average of $22.75 and a 200 day simple moving average of $22.66. Phibro Animal Health Co. has a 52 week low of $12.17 and a 52 week high of $26.55. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities research analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.21%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's payout ratio is currently 100.00%.
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
